Literature DB >> 2179966

Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice.

B A Diwan1, J M Rice, J M Ward.   

Abstract

Inbred strains of mice were found to differ significantly in their susceptibility to liver tumor promotion by PB. The susceptibility to promotion of hepatocarcinogenesis by this drug was a dominant trait in crosses between the sensitive DBA and resistant C57 mice. The reciprocal F1 hybrids responded similarly to tumor promotion by PB. PB promoted the development of hepatoblastomas in D2B6F1 males but not in B6D2F1 mice. Female mice of the D2B6F1 cross, similarly exposed to PB, failed to develop hepatoblastomas. These results suggested a sex-linked differential response to the development of hepatoblastomas in reciprocal F1 hybrids that are genetically identical except for the reverse origin of their X and Y chromosomes. Differences in the promoting effects of PB between C57 and DBA mice appeared to correlate with differences in the metabolism/detoxification of this drug. In conclusion, mouse strains that differ in susceptibility to two-stage liver carcinogenesis provide excellent opportunities to investigate the genetic and/or biochemical mechanisms responsible for these differences. Understanding these mechanisms may lead to the identification of factors that affect liver tumor development not only in mice but in other species as well.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179966

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  8 in total

1.  Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancer.

Authors:  Jessica M Ellis; David S Paul; Michael A Depetrillo; Bhanu P Singh; David E Malarkey; Rosalind A Coleman
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

2.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Authors:  Nicole M Kettner; Horatio Voicu; Milton J Finegold; Cristian Coarfa; Arun Sreekumar; Nagireddy Putluri; Chinenye A Katchy; Choogon Lee; David D Moore; Loning Fu
Journal:  Cancer Cell       Date:  2016-11-23       Impact factor: 31.743

4.  Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.

Authors:  Scharri J Ezell; Haibo Li; Hongxia Xu; Xiangrong Zhang; Evrim Gurpinar; Xu Zhang; Elizabeth R Rayburn; Charnell I Sommers; Xinyi Yang; Sadanandan E Velu; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2010-07-13       Impact factor: 5.118

5.  Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta1.

Authors:  Monika Chabicovsky; Ute Wastl; Henryk Taper; Bettina Grasl-Kraupp; Rolf Schulte-Hermann; Wilfried Bursch
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-06       Impact factor: 4.553

6.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

7.  Progression of Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital.

Authors:  Anna Kakehashi; Naomi Ishii; Takahiro Okuno; Masaki Fujioka; Min Gi; Shoji Fukushima; Hideki Wanibuchi
Journal:  Oxid Med Cell Longev       Date:  2017-07-13       Impact factor: 6.543

Review 8.  The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk.

Authors:  Allan Balmain
Journal:  Nat Genet       Date:  2020-10-26       Impact factor: 38.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.